A Bystritsky

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint Interactions between diabetes and anxiety and depression: implications for treatment
    Alexander Bystritsky
    Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, 300 UCLA Medical Plaza, Room 2330, Los Angeles, CA 90095 6968, USA Electronic address
    Endocrinol Metab Clin North Am 43:269-83. 2014
  2. doi request reprint Use of complementary and alternative medicine in a large sample of anxiety patients
    Alexander Bystritsky
    Department of Psychiatry and Biobehavioral Science, University of California, Los Angeles, CA 90095, USA
    Psychosomatics 53:266-72. 2012
  3. doi request reprint Computational non-linear dynamical psychiatry: a new methodological paradigm for diagnosis and course of illness
    A Bystritsky
    Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, United States
    J Psychiatr Res 46:428-35. 2012
  4. ncbi request reprint A pilot controlled trial of bupropion XL versus escitalopram in generalized anxiety disorder
    Alexander Bystritsky
    Department of Psychiatry, University of California, Los Angeles, CA, USA
    Psychopharmacol Bull 41:46-51. 2008
  5. pmc Focused ultrasound-mediated suppression of chemically-induced acute epileptic EEG activity
    Byoung Kyong Min
    Department of Radiology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    BMC Neurosci 12:23. 2011
  6. ncbi request reprint A pilot study of cranial electrotherapy stimulation for generalized anxiety disorder
    Alexander Bystritsky
    Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA 90095 6968, USA
    J Clin Psychiatry 69:412-7. 2008
  7. doi request reprint A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD)
    Alexander Bystritsky
    Department of Psychiatry, University of California, Los Angeles, CA, USA
    J Altern Complement Med 14:175-80. 2008
  8. ncbi request reprint Treatment-resistant anxiety disorders
    A Bystritsky
    UCLA, Department of Psychiatry, Los Angeles, CA 90095 6968, USA
    Mol Psychiatry 11:805-14. 2006
  9. pmc Clinical and subthreshold panic disorder
    Alexander Bystritsky
    The Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, California 90095 8346, USA
    Depress Anxiety 27:381-9. 2010
  10. ncbi request reprint Quality-of-life changes among patients with obsessive-compulsive disorder in a partial hospitalization program
    A Bystritsky
    University of California, Los Angeles, Neuropsychiatric Institute and Hospital, 90024, USA
    Psychiatr Serv 50:412-4. 1999

Detail Information

Publications49

  1. doi request reprint Interactions between diabetes and anxiety and depression: implications for treatment
    Alexander Bystritsky
    Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, 300 UCLA Medical Plaza, Room 2330, Los Angeles, CA 90095 6968, USA Electronic address
    Endocrinol Metab Clin North Am 43:269-83. 2014
    ..These components combine, interact, and reassemble to create a precarious system for persons with, or predisposed to, diabetes. Clinicians must be aware of these interrelationships to adequately treat the disease. ..
  2. doi request reprint Use of complementary and alternative medicine in a large sample of anxiety patients
    Alexander Bystritsky
    Department of Psychiatry and Biobehavioral Science, University of California, Los Angeles, CA 90095, USA
    Psychosomatics 53:266-72. 2012
    ..To examine a large sample of patients with anxiety and the association between types of complementary and alternative treatments that were used, demographic variables, diagnostic categories, and treatment outcomes...
  3. doi request reprint Computational non-linear dynamical psychiatry: a new methodological paradigm for diagnosis and course of illness
    A Bystritsky
    Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, United States
    J Psychiatr Res 46:428-35. 2012
    ..They may also provide a new, more descriptive and ultimately more predictive approach leading to better understanding of the interrelationship between psychological, neurobiological, and genetic underpinnings of mental illness...
  4. ncbi request reprint A pilot controlled trial of bupropion XL versus escitalopram in generalized anxiety disorder
    Alexander Bystritsky
    Department of Psychiatry, University of California, Los Angeles, CA, USA
    Psychopharmacol Bull 41:46-51. 2008
    ..To compare the efficacy and safety of bupropion XL (150 to 300 mg/day) with the selective serotonin reuptake inhibitor escitalopram (10 to 20 mg/day) in outpatients diagnosed with generalized anxiety disorder (GAD)...
  5. pmc Focused ultrasound-mediated suppression of chemically-induced acute epileptic EEG activity
    Byoung Kyong Min
    Department of Radiology, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    BMC Neurosci 12:23. 2011
    ....
  6. ncbi request reprint A pilot study of cranial electrotherapy stimulation for generalized anxiety disorder
    Alexander Bystritsky
    Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA 90095 6968, USA
    J Clin Psychiatry 69:412-7. 2008
    ..The goal of this study was to evaluate the efficacy of CES in alleviating anxiety in patients with DSM-IV-diagnosed GAD...
  7. doi request reprint A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD)
    Alexander Bystritsky
    Department of Psychiatry, University of California, Los Angeles, CA, USA
    J Altern Complement Med 14:175-80. 2008
    ..Whether R. rosea is effective in reducing similar symptoms in clinical samples is unknown. The goal of this pilot study was to evaluate whether R. rosea is effective in reducing symptoms of generalized anxiety disorder (GAD)...
  8. ncbi request reprint Treatment-resistant anxiety disorders
    A Bystritsky
    UCLA, Department of Psychiatry, Los Angeles, CA 90095 6968, USA
    Mol Psychiatry 11:805-14. 2006
    ..In addition, we would like to review current strategies that could be helpful in reducing treatment resistance and aiding people chronically suffering from these severe and disabling conditions...
  9. pmc Clinical and subthreshold panic disorder
    Alexander Bystritsky
    The Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, California 90095 8346, USA
    Depress Anxiety 27:381-9. 2010
    ..The purpose of this study was to add to the accumulating evidence of significant comorbidity and disability associated with subthreshold PD...
  10. ncbi request reprint Quality-of-life changes among patients with obsessive-compulsive disorder in a partial hospitalization program
    A Bystritsky
    University of California, Los Angeles, Neuropsychiatric Institute and Hospital, 90024, USA
    Psychiatr Serv 50:412-4. 1999
    ..No significant association between changes in YBOCS scores and QOL scores was found...
  11. ncbi request reprint A preliminary study of fMRI-guided rTMS in the treatment of generalized anxiety disorder
    Alexander Bystritsky
    Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA 90095 6968, USA
    J Clin Psychiatry 69:1092-8. 2008
    ..The goal of this pilot study was to evaluate whether functional magnetic resonance imaging (fMRI)-guided rTMS is effective in reducing symptoms of GAD...
  12. doi request reprint A review of low-intensity focused ultrasound pulsation
    Alexander Bystritsky
    Semel Institute for Neuroscience and Human Behavior, David Geffen School of Medicine, University of California, Los Angeles, 90095, USA
    Brain Stimul 4:125-36. 2011
    ..In this study, we review over 50 years of research data on the use of focused ultrasound (FUS) in neuronal tissue and live brain, and propose novel applications of this noninvasive neuromodulation method...
  13. ncbi request reprint Social functioning and quality of life comparisons between obsessive-compulsive and schizophrenic disorders
    A Bystritsky
    UCLA Department of Psychiatry and Biobehavioral Sciences, 300 UCLA Medical Plaza, Los Angeles, California 90095, USA
    Depress Anxiety 14:214-8. 2001
    ..We concluded that patients with severe OCD and patients with schizophrenia are equally socially impaired. However, OCD patients experience greater significant functional improvement with multimodal treatment...
  14. ncbi request reprint A retrospective review of clinical characteristics and treatment response in body dysmorphic disorder versus obsessive-compulsive disorder
    S Saxena
    Department of Psychiatry and Biobehavioral Sciences, UCLA Neuropsychiatric Institute, Los Angeles, Calif 90095, USA
    J Clin Psychiatry 62:67-72; quiz 73. 2001
    ..Although BDD and OCD respond to similar medications and cognitive-behavioral therapy (CBT), their response to treatment has never been directly compared...
  15. pmc Predictors of clinical improvement in a randomized effectiveness trial for primary care patients with panic disorder
    Denise A Chavira
    Department of Psychiatry, University of California, San Diego, CA 92037, USA
    J Nerv Ment Dis 197:715-21. 2009
    ..A greater understanding of these predictors may help clinicians identify who is at greatest risk for persistent panic-related symptoms and to plan the intensity of interventions accordingly...
  16. ncbi request reprint Quality of care for primary care patients with anxiety disorders
    Murray B Stein
    Department of Psychiatry, University of California, San Diego, 9500 Gilman Dr, La Jolla, CA 92093 0985, USA
    Am J Psychiatry 161:2230-7. 2004
    ..This study evaluated quality of care for primary care patients with anxiety disorders in university-affiliated outpatient clinics in Los Angeles, San Diego, and Seattle...
  17. ncbi request reprint Pilot open-label study of nefazodone in panic disorder
    A Bystritsky
    Department of Psychiatry, U C L A School of Medicine, USA
    Depress Anxiety 10:137-9. 1999
    ..Low sample size and absence of placebo control indicate the need for a large placebo-controlled trial. The results of this pilot study suggest that nefazodone may be promising in the treatment of panic and justify further research...
  18. pmc Impaired identity recognition of faces with emotional expressions in body dysmorphic disorder
    Jamie Donald Feusner
    Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA, USA
    Psychiatry Res 179:318-23. 2010
    ..This could reflect fundamental abnormalities in visual information processing that are more pronounced for emotional expressions in general, and may relate to their perceptual disturbances...
  19. ncbi request reprint CBT intensity and outcome for panic disorder in a primary care setting
    Michelle G Craske
    University of California, Los Angeles, Los Angeles, CA 90095 1563, USA
    Behav Ther 37:112-9. 2006
    ..The significance of follow-up booster phone contact is discussed as an index of continued self-management of panic and anxiety following acute treatment...
  20. pmc Disorder-specific impact of coordinated anxiety learning and management treatment for anxiety disorders in primary care
    Michelle G Craske
    Department of Psychology, University of California at Los Angeles, Los Angeles, CA 90095 1563, USA
    Arch Gen Psychiatry 68:378-88. 2011
    ..Anxiety disorders commonly present in primary care, where evidence-based mental health treatments often are unavailable or suboptimally delivered...
  21. pmc Regional brain volumes and symptom severity in body dysmorphic disorder
    Jamie D Feusner
    Department of Psychiatry, University of California, Los Angeles, CA 90095, United States
    Psychiatry Res 172:161-7. 2009
    ..These are in concordance with the involvement of these regions in pathological face processing, which may contribute to the primary symptomatology...
  22. pmc Treatment for anxiety disorders: Efficacy to effectiveness to implementation
    Michelle G Craske
    University of California, Los Angeles, Department of Psychology, Franz Hall, 405 Hilgard Avenue, Los Angeles, CA 90095, USA
    Behav Res Ther 47:931-7. 2009
    ..Future directions for our research include dissemination and implementation of the CALM program, testing potential alternations to the CALM program, and distance delivery of CALM...
  23. ncbi request reprint Obsessive-compulsive hoarding: symptom severity and response to multimodal treatment
    Sanjaya Saxena
    Department of Psychiatry and Biobehavioral Sciences, UCLA Neuropsychiatric Institute, Los Angeles, Calif 90095, USA
    J Clin Psychiatry 63:21-7. 2002
    ....
  24. ncbi request reprint Functional impact and health utility of anxiety disorders in primary care outpatients
    Murray B Stein
    Department of Psychiatry, University of California San Diego, La Jolla, CA 92093 0985, USA
    Med Care 43:1164-70. 2005
    ..The objective of this study was to examine the relative impact of anxiety disorders and major depression on functional status and health-related quality of life of primary care outpatients...
  25. ncbi request reprint Does the addition of cognitive behavioral therapy improve panic disorder treatment outcome relative to medication alone in the primary-care setting?
    Michelle G Craske
    Department of Psychology, University of California Los Angeles, 405 Holgard Avenue, Los Angeles, CA 90095, USA
    Psychol Med 35:1645-54. 2005
    ..Using an as-treated analysis, we evaluated whether the addition of CBT enhanced outcomes for panic disorder relative to medications alone in the primary-care setting...
  26. ncbi request reprint Efficacy of low and higher dose extended-release venlafaxine in generalized social anxiety disorder: a 6-month randomized controlled trial
    Murray B Stein
    Department of Psychiatry, University of California San Diego, 9500 Gilman Drive, La Jolla, CA 92093 0985, USA
    Psychopharmacology (Berl) 177:280-8. 2005
    ..There is a need for new pharmacological treatments for generalized social anxiety disorder (GSAD), which is a common, often disabling condition...
  27. ncbi request reprint Presleep attributions about arousal during sleep: nocturnal panic
    Michelle G Craske
    Department of Psychology, University of California, Los Angeles 90095 1563, USA
    J Abnorm Psychol 111:53-62. 2002
    ..The findings are consistent with a cognitive model of nocturnal panic attacks...
  28. ncbi request reprint Perceived unmet need for mental health treatment and barriers to care among patients with panic disorder
    Michelle G Craske
    University of California, Los Angeles, CA 90024 1563, USA
    Psychiatr Serv 56:988-94. 2005
    ..This study estimated the extent of perceived unmet need for mental health treatment among individuals with panic disorder in primary care settings, investigated the determinants of unmet need, and assessed barriers to care...
  29. ncbi request reprint Treating panic disorder in primary care: a collaborative care intervention
    Michelle G Craske
    Department of Psychology, UCLA, Los Angeles, CA, USA
    Gen Hosp Psychiatry 24:148-55. 2002
    ..This description is intended to lay the groundwork for continued research efforts in the extension of efficacious treatments into primary care settings...
  30. ncbi request reprint Visual information processing of faces in body dysmorphic disorder
    Jamie D Feusner
    Department of Psychiatry and Biobehavioral Sciences, David Geffen School of Medicine at the University of California, Los Angeles, 300 UCLA Medical Plaza, Ste 2345, Los Angeles, CA 90024, USA
    Arch Gen Psychiatry 64:1417-25. 2007
    ..This study examines abnormalities in visual information processing in BDD that may underlie clinical symptoms...
  31. ncbi request reprint Augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder using adjunctive olanzapine: a placebo-controlled trial
    Alexander Bystritsky
    Department of Psychiatry and Biobehavioral Sciences, Anxiety Disorders Program, University of California Los Angeles School of Medicine, Neuropsychiatric Institute and Hospital, 300 UCLA Medical Plaza, Los Angeles, CA 90095, USA
    J Clin Psychiatry 65:565-8. 2004
    ..The purpose of this study was to explore the efficacy of adding an atypical antipsychotic, olanzapine, to a serotonin reuptake inhibitor (SRI) in treatment-refractory obsessive-compulsive disorder (OCD)...
  32. ncbi request reprint Development of a brief diagnostic screen for panic disorder in primary care
    M B Stein
    Department of Psychiatry, University of California, San Diego, La Jolla 92093 0985, USA
    Psychosom Med 61:359-64. 1999
    ..The purpose of this study was to determine the utility of a brief screening tool for panic disorder in the primary care setting...
  33. pmc Validation of a brief measure of anxiety-related severity and impairment: the Overall Anxiety Severity and Impairment Scale (OASIS)
    Laura Campbell-Sills
    Department of Psychiatry, University of California, San Diego, La Jolla, CA 92093 0603, USA
    J Affect Disord 112:92-101. 2009
    ..A prior investigation with a nonclinical sample supported the reliability and validity of the OASIS; however, to date it has not been validated for use in clinical samples...
  34. ncbi request reprint Does nocturnal panic represent a more severe form of panic disorder?
    Michelle G Craske
    Department of Psychology, UCLA, 405 Hilgard Ave, Los Angeles, CA 90095 1563 Send reprint requests to Dr Craske
    J Nerv Ment Dis 190:611-8. 2002
    ..The authors conclude that NP may be a specific version of panic disorder characterized by fearful associations with sleep and sleeplike states...
  35. ncbi request reprint Predictors of willingness to consider medication and psychosocial treatment for panic disorder in primary care patients
    Holly Hazlett-Stevens
    University of California, Los Angeles, CA, USA
    Gen Hosp Psychiatry 24:316-21. 2002
    ....
  36. ncbi request reprint Fluoxetine treatment and testosterone levels
    Stewart Bell
    Private Practice, Arcadia, CA, USA
    Ann Clin Psychiatry 18:19-22. 2006
    ..As decreased testosterone has several negative health effects, we conducted a pilot study investigating the effect of fluoxetine treatment on testosterone levels...
  37. pmc Computer-assisted delivery of cognitive behavioral therapy for anxiety disorders in primary-care settings
    Michelle G Craske
    Department of Psychology, University of California, Los Angeles, California, USA
    Depress Anxiety 26:235-42. 2009
    ..The purpose of the current report is to (1) present the structure and format of the computer-assisted CBT program, and (2) to present evidence for acceptance of the program by clinicians and the effectiveness of the program for patients...
  38. ncbi request reprint Assessment of beliefs about psychotropic medication and psychotherapy: development of a measure for patients with anxiety disorders
    Alexander Bystritsky
    Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, CA 90095, USA
    Gen Hosp Psychiatry 27:313-8. 2005
    ..This study presents the psychometric properties of a brief measure to assess beliefs about psychotropic medications and psychotherapy among patients with anxiety disorders...
  39. ncbi request reprint Functional MRI changes during panic anticipation and imagery exposure
    A Bystritsky
    Department of Psychiatry, UCLA/NPI, 300 UCLA Medical Plaza, 2335 Los Angeles, CA 90095, USA
    Neuroreport 12:3953-7. 2001
    ..We propose that this pattern of activity may enhance the encoding and retrieval of strong emotional events, facilitating the recapitulation of traumatic experiences and leading to panic disorder in vulnerable individuals...
  40. ncbi request reprint The Composite International Diagnostic Interview (CIDI-Auto): problems and remedies for diagnosing panic disorder and social phobia
    Adrienne Means-Christensen
    University of California, San Diego, CA 92037, USA
    Int J Methods Psychiatr Res 12:167-81. 2003
    ..We did not examine the false positive rate for the unmodified or modified CIDI, but this is an important issue that needs to be evaluated in future research...
  41. ncbi request reprint Quetiapine augmentation in obsessive-compulsive disorder resistant to serotonin reuptake inhibitors: an open-label study
    Ann M Bogan
    Department of Psychiatry and Behavioral Sciences, Stanford University Medical Center, Stanford, CA 94305, USA
    J Clin Psychiatry 66:73-9. 2005
    ..Case series reporting successful augmentation with risperidone and olanzapine led us to investigate quetiapine in OCD that was resistant to SRI treatment...
  42. pmc Design of the Coordinated Anxiety Learning and Management (CALM) study: innovations in collaborative care for anxiety disorders
    Greer Sullivan
    South Central VA Mental Illness Research Education and Clinical Center, Central Arkansas Veterans Healthcare System, North Little Rock, AR 72214 1706, USA
    Gen Hosp Psychiatry 29:379-87. 2007
    ..Since anxiety disorders are most often treated in primary care, quality improvement interventions, such as the Coordinated Anxiety Learning and Management (CALM) intervention, are needed in primary care...
  43. pmc A randomized effectiveness trial of cognitive-behavioral therapy and medication for primary care panic disorder
    Peter P Roy-Byrne
    Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine at Harborview Medical Center, Seattle, USA
    Arch Gen Psychiatry 62:290-8. 2005
    ..Although numerous studies have assessed the effectiveness of treatments for depression in primary care, few such studies have been conducted for panic disorder...
  44. ncbi request reprint Beliefs about psychotropic medication and psychotherapy among primary care patients with anxiety disorders
    Amy W Wagner
    Department of Psychiatry and Behavioral Sciences, University of Washington School of Medicine at Harborview Medical Center, Seattle, Washington 98104 2499, USA
    Depress Anxiety 21:99-105. 2005
    ..Treatment adherence may therefore be increased by addressing these beliefs directly...
  45. ncbi request reprint Moving treatment research from clinical trials to the real world
    Peter P Roy-Byrne
    Department of Psychiatry and Behavioral Sciences, University of Washington at Harborview Medical Center, Seattle 98014, USA
    Psychiatr Serv 54:327-32. 2003
    ....
  46. ncbi request reprint Use of herbal medicine in primary care patients with mood and anxiety disorders
    Peter P Roy-Byrne
    Department of Psychiatry and Behavioral Sciences, Harborview Medical Center, University of Washington School of Medicine, Box 359911, 325 9th Ave, Seattle, WA 98104, USA
    Psychosomatics 46:117-22. 2005
    ..Use was not associated with receipt of pharmacotherapy or psychotherapy for anxiety or depression...
  47. doi request reprint The effect of attributional processes concerning medication taking on return of fear
    Mark B Powers
    Faculty of Social and Behavioral Sciences, University of Amsterdam, Amsterdam, The Netherlands
    J Consult Clin Psychol 76:478-90. 2008
    ..These findings highlight the importance of assessing patient attributions regarding the improvements achieved with combined exposure-based and pharmacological treatments for anxiety disorders...
  48. ncbi request reprint St John's wort versus placebo in obsessive-compulsive disorder: results from a double-blind study
    Kenneth A Kobak
    Dean Foundation for Health Research and Education, Middleton, Wisconsin 53562, USA
    Int Clin Psychopharmacol 20:299-304. 2005
    ..9%) and placebo (16.7%) (P=0.905). Only one patient from each group discontinued due to adverse events [sinus infection (St John's wort); confusion (placebo)]. The results fail to support the efficacy of St John's wort for OCD...
  49. ncbi request reprint Improving clinical trials: American Society of Clinical Psychopharmacology recommendations
    Donald F Klein
    New York State Psychiatric Institute and Columbia University, Unit 22, 1051 Riverside Dr, New York, NY 10032, USA
    Arch Gen Psychiatry 59:272-8. 2002
    ..The scope of inquiry included identifying means of shifting institutional and regulatory assumptions and processes, even to the point of seeking appropriate national incentives...